News Focus
News Focus
Replies to #41450 on Biotech Values
icon url

DewDiligence

02/01/07 12:14 PM

#41452 RE: xrymd #41450

> ARTE – I knew this announcement was coming several weeks back but did not profit from it.<

Do you know the actual side-effect numbers?

>facial granulomas happen with all of the products…<

But they are obviously less of a problem with shorter-duration products.

>… and are treated with a steroid injection<

How often does this solve the problem to the patient’s satisfaction?

What about my comment re selection bias in the five-year results? T.i.a. Dew
icon url

DewDiligence

02/22/07 1:19 PM

#42368 RE: xrymd #41450

ARTE – The Roth webcast included a slide that showed a 2.1% rate of moderate/severe AEs. This seems worrisome for a cosmetic procedure.

I was waiting for Diane Goostree to address the recent finding that Restylane’s collagen generation increases its duration of effect (#msg-17194621). Alas, she chose to ignore it. I think this finding will prove to be the nail in the coffin for ARTE.